07 Sep 2020 --- In order to allow hemp and hemp-derived cannabidiol (CBD) to be legally marketed in dietary supplements, US bipartisan legislation has been put forward by Congress representatives. The bill directs the US Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp-derived CBD and assure consumer protection. The move has elicited positive response from the supplements industry, which flags that it would protect public health by providing legal clarity in the CBD product marketplace.